<?xml version="1.0"?>
<template xmlns:xsd="http://www.w3.org/2001/XMLSchema" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xmlns="openEHR/v1/Template">
  <id>bac4049d-ffc2-44e9-a65a-b6cb337e3588</id>
  <name>Antiemetics Adult Order Panel</name>
  <description>
    <lifecycle_state>Initial</lifecycle_state>
    <details>
      <purpose/>
      <use/>
      <misuse/>
    </details>
    <other_details>
      <item>
        <key>MetaDataSet:Sample Set </key>
        <value>Template metadata sample set </value>
      </item>
      <item>
        <key>Acknowledgements</key>
        <value/>
      </item>
      <item>
        <key>Business Process Level</key>
        <value/>
      </item>
      <item>
        <key>Care setting</key>
        <value/>
      </item>
      <item>
        <key>Client group</key>
        <value/>
      </item>
      <item>
        <key>Clinical Record Element</key>
        <value/>
      </item>
      <item>
        <key>Copyright</key>
        <value/>
      </item>
      <item>
        <key>Issues</key>
        <value/>
      </item>
      <item>
        <key>Owner</key>
        <value/>
      </item>
      <item>
        <key>Sign off</key>
        <value/>
      </item>
      <item>
        <key>Speciality</key>
        <value/>
      </item>
      <item>
        <key>User roles</key>
        <value/>
      </item>
    </other_details>
  </description>
  <annotations path="[openEHR-EHR-SECTION.adhoc.v1]">
    <items>
      <item>
        <key>Technical.ï»© Technical Traceability</key>
        <value>{~AHSID~bac4049d-ffc2-44e9-a65a-b6cb337e3588~NAME~Antiemetics Adult Order Panel}</value>
      </item>
    </items>
  </annotations>
  <annotations path="[openEHR-EHR-SECTION.adhoc.v1]/items[openEHR-EHR-SECTION.clinical_guidance.v1 and name/value=&apos;Clinical Guidance #1&apos;]">
    <items>
      <item>
        <key>CKT.Clinical Guidance</key>
        <value>&lt;p&gt;Avoid dimenhyDRINATE in patients 65 years of age or older due to increased risk of side effects including delirium. Maximum 400 mg per 24 hours.&lt;/p&gt;</value>
      </item>
    </items>
  </annotations>
  <annotations path="[openEHR-EHR-SECTION.adhoc.v1]/items[openEHR-EHR-SECTION.clinical_guidance.v1 and name/value=&apos;Clinical Guidance&apos;]">
    <items>
      <item>
        <key>CKT.Clinical Guidance</key>
        <value>&lt;p&gt;PO administration or slow infusion via IVPB are preferred for metoclopramide to reduce the risk of akathisia. Suggest 5 mg for mild/moderate nausea or if CrCl less than 40mL/min; 10-20 mg for moderate/severe nausea, and CrCl over 40mL/min.&lt;/p&gt;&lt;p&gt;Use with caution in the elderly due to increased CNS side effects.&lt;/p&gt;</value>
      </item>
    </items>
  </annotations>
  <annotations path="[openEHR-EHR-SECTION.adhoc.v1]/items[openEHR-EHR-SECTION.clinical_guidance.v1 and name/value=&apos;Clinical Guidance #2&apos;]">
    <items>
      <item>
        <key>CKT.Clinical Guidance</key>
        <value>&lt;p&gt;4 mg starting dose recommended for IV ondansetron and 4 mg PO for geriatric patients&lt;/p&gt;</value>
      </item>
    </items>
  </annotations>
  <annotations path="[openEHR-EHR-SECTION.adhoc.v1]/items[openEHR-EHR-SECTION.clinical_guidance.v1 and name/value=&apos;Clinical Guidance #3&apos;]">
    <items>
      <item>
        <key>CKT.Clinical Guidance</key>
        <value>&lt;p&gt;For patients actively vomiting without an IV access, ondansetron ODT can be used&lt;/p&gt;</value>
      </item>
    </items>
  </annotations>
  <definition xsi:type="SECTION" archetype_id="openEHR-EHR-SECTION.adhoc.v1" concept_name="Ad hoc heading" max="1" name="Antiemetics">
    <Item xsi:type="SECTION" archetype_id="openEHR-EHR-SECTION.clinical_guidance.v1" concept_name="Clinical Guidance" max="1" path="/items" name="Clinical Guidance #1">
      <Item xsi:type="INSTRUCTION" archetype_id="openEHR-EHR-INSTRUCTION.service_request.v1" template_id="518ff2cd-715c-4eff-99e5-6678da8a95ac" concept_name="PHARM dimenhyDRINATE Tablet Order" max="1" path="/items" name="dimenhyDRINATE tablet; 50 mg PO once"/>
      <Item xsi:type="INSTRUCTION" archetype_id="openEHR-EHR-INSTRUCTION.service_request.v1" template_id="518ff2cd-715c-4eff-99e5-6678da8a95ac" concept_name="PHARM dimenhyDRINATE Tablet Order" max="1" path="/items" name="dimenhyDRINATE tablet; 25 to 50 mg PO every 4 hours PRN for nausea/vomiting"/>
      <Item xsi:type="INSTRUCTION" archetype_id="openEHR-EHR-INSTRUCTION.service_request.v1" template_id="4b92a969-5e3f-4eed-9f4a-1ee889f2b8b1" concept_name="PHARM dimenhyDRINATE Suppository Order" max="1" path="/items" name="dimenhyDRINATE suppository; 50 mg RECTALLY once"/>
      <Item xsi:type="INSTRUCTION" archetype_id="openEHR-EHR-INSTRUCTION.service_request.v1" template_id="4b92a969-5e3f-4eed-9f4a-1ee889f2b8b1" concept_name="PHARM dimenhyDRINATE Suppository Order" max="1" path="/items" name="dimenhyDRINATE suppository; 50 mg RECTALLY every 8 hours PRN for nausea/vomiting"/>
      <Item xsi:type="INSTRUCTION" archetype_id="openEHR-EHR-INSTRUCTION.service_request.v1" template_id="b3470f1f-dbbe-484a-a690-f8a12001c2f8" concept_name="PHARM dimenhyDRINATE injection Order" max="1" path="/items" name="dimenhyDRINATE IV/IM; 50 mg IV once"/>
      <Item xsi:type="INSTRUCTION" archetype_id="openEHR-EHR-INSTRUCTION.service_request.v1" template_id="b3470f1f-dbbe-484a-a690-f8a12001c2f8" concept_name="PHARM dimenhyDRINATE injection Order" max="1" path="/items" name="dimenhyDRINATE IV/IM; 25 to 50 mg IV every 4 hours PRN for nausea/vomiting"/>
    </Item>
    <Item xsi:type="SECTION" archetype_id="openEHR-EHR-SECTION.clinical_guidance.v1" concept_name="Clinical Guidance" path="/items">
      <Item xsi:type="INSTRUCTION" archetype_id="openEHR-EHR-INSTRUCTION.service_request.v1" template_id="05b202cc-0015-412c-9c83-ed0c7727d1f0" concept_name="PHARM metoclopramide Tablet Order" max="1" path="/items" name="metoclopramide tablet; 10 mg PO once"/>
      <Item xsi:type="INSTRUCTION" archetype_id="openEHR-EHR-INSTRUCTION.service_request.v1" template_id="05b202cc-0015-412c-9c83-ed0c7727d1f0" concept_name="PHARM metoclopramide Tablet Order" max="1" path="/items" name="metoclopramide tablet; 10 mg PO every 6 hours PRN for nausea/vomiting"/>
      <Item xsi:type="INSTRUCTION" archetype_id="openEHR-EHR-INSTRUCTION.service_request.v1" template_id="a9b485b3-6681-44f9-b0fb-1949efbd6d85" concept_name="PHARM metoclopramide injection Order" max="1" path="/items" name="metoclopramide IV/IM/SC; 10 mg IV once"/>
      <Item xsi:type="INSTRUCTION" archetype_id="openEHR-EHR-INSTRUCTION.service_request.v1" template_id="a9b485b3-6681-44f9-b0fb-1949efbd6d85" concept_name="PHARM metoclopramide injection Order" max="1" path="/items" name="metoclopramide IV/IM/SC; 10 mg IV every 6 hours PRN for nausea/vomiting"/>
    </Item>
    <Item xsi:type="SECTION" archetype_id="openEHR-EHR-SECTION.clinical_guidance.v1" concept_name="Clinical Guidance" max="1" path="/items" name="Clinical Guidance #2">
      <Item xsi:type="INSTRUCTION" archetype_id="openEHR-EHR-INSTRUCTION.service_request.v1" template_id="ceb70162-69de-42da-b231-05ff8dbc8eae" concept_name="PHARM ondansetron Tablet Order" max="1" path="/items" name="ondansetron tablet; 4 mg PO every 8 hours PRN for nausea/vomiting"/>
      <Item xsi:type="INSTRUCTION" archetype_id="openEHR-EHR-INSTRUCTION.service_request.v1" template_id="80b79825-a35f-40f3-ba6f-030ce06fa116" concept_name="PHARM ondansetron injection Order" max="1" path="/items" name="ondansetron injection; 4 mg IV once"/>
      <Item xsi:type="INSTRUCTION" archetype_id="openEHR-EHR-INSTRUCTION.service_request.v1" template_id="80b79825-a35f-40f3-ba6f-030ce06fa116" concept_name="PHARM ondansetron injection Order" max="1" path="/items" name="ondansetron injection; 4 mg IV every 8 hours PRN for nausea/vomiting"/>
    </Item>
    <Item xsi:type="SECTION" archetype_id="openEHR-EHR-SECTION.clinical_guidance.v1" concept_name="Clinical Guidance" max="1" path="/items" name="Clinical Guidance #3">
      <Item xsi:type="INSTRUCTION" archetype_id="openEHR-EHR-INSTRUCTION.service_request.v1" template_id="a7014313-c3f3-4fc4-9077-6d796f649b99" concept_name="PHARM ondansetron Oral disintegrating tablet Order" max="1" path="/items" name="ondansetron ODT tablet; 4 mg PO every 8 hours PRN for nausea/vomiting"/>
    </Item>
  </definition>
  <integrity_checks xsi:type="ArchetypeIntegrity" archetype_id="openEHR-EHR-SECTION.adhoc.v1">
    <digest id="MD5-CAM-1.0.1">8AE70853975A75254E6D39A8DE3652AF</digest>
  </integrity_checks>
  <integrity_checks xsi:type="ArchetypeIntegrity" archetype_id="openEHR-EHR-SECTION.clinical_guidance.v1">
    <digest id="MD5-CAM-1.0.1">4B2F0F6CD593E442DA9C30277A3EA9CF</digest>
  </integrity_checks>
  <integrity_checks xsi:type="ArchetypeIntegrity" archetype_id="openEHR-EHR-INSTRUCTION.service_request.v1">
    <digest id="MD5-CAM-1.0.1">AD8DFB192E67715F0D9E11E95E674AD0</digest>
  </integrity_checks>
  <integrity_checks xsi:type="ArchetypeIntegrity" archetype_id="openEHR-EHR-CLUSTER.service_request_information.v1">
    <digest id="MD5-CAM-1.0.1">230A8D964017E1FD7AC82EBDEE0202A6</digest>
  </integrity_checks>
</template>